🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Exclusive: Ayana Renewable to raise Rs 150 Cr from IL&FS Mutual Fund

EntrackrEntrackr · 7m ago
Exclusive: Ayana Renewable to raise Rs 150 Cr from IL&FS Mutual Fund
Medial

Exclusive: Ayana Renewable to raise Rs 150 Cr from IL&FS Mutual Fund Renewable energy firm Ayana Renewable is set to raise Rs 150 crore (approximately $17.4 million) in debt from IL&FS Mutual Fund. This development came a month after the company had signed a share purchase agreement with ONGC-NTPC Joint Venture. The board at Ayana Renewable has passed a special resolution to issue 1,500 non-convertible debentures at an issue price of Rs 10,00,000 each to raise Rs 150 crore, its regulatory filing accessed from the RoC. The funds will be used for debt refinancing, subsidiary support in renewable projects, interest, loans, and other eligible infrastructure needs. Notably, the tenure of these debentures will be 3 years from the date of initial drawdown. Ayana Renewable operates as an asset-heavy IPP, developing and managing solar and wind projects with long-term PPAs. Backed by NIIF and global investors, it funds growth through equity, debt, and bonds while ensuring efficient operations and exploring hybrid energy, battery storage, and green hydrogen. Last month, NIIF, British International Investment, and Eversource Capital signed a share purchase agreement to sell their 100% stake to ONGC NTPC Green Pvt. Ltd. (ONGPL), a 50:50 JV of ONGC Green Ltd. (OGL) and NTPC Green Energy Ltd. (NGEL), for an enterprise value of $2.3 billion. For context, Ayana was set up by BII in 2018 and secured over $700 million from NIIF, BII, and Eversource to date. Last week, CCI approved the above-mentioned share agreement. Ayana's scale saw a modest 4% year-on-year growth to Rs 856 crore in FY24 from Rs 823 crore in FY23. However, the company's profits declined sharply by 42.3% to Rs 45 crore during the same period.

9

Related News

Exclusive: FableStreet parent FS Life to raise $4 Mn in Series B

EntrackrEntrackr · 19d ago
Exclusive: FableStreet parent FS Life to raise $4 Mn in Series B
Medial

Exclusive: FableStreet parent FS Life to raise $4 Mn in Series B FS Life, the parent company of D2C women's fashion brand FableStreet, is raising Rs 35.54 crore (around $4 million) led by Colossa Ventures with the participation of existing investor Fireside Ventures and others. FS Life, the parent company of D2C women's fashion brand FableStreet, is raising Rs 35.54 crore (around $4 million) led by Colossa Ventures with the participation of existing investor Fireside Ventures, HirePro Consulting, ASA Holdings, NKA Resources and other angel investors. This is the first fundraise for the company in 3 years since it raised Rs 50 crore in its pre-Series B round led by Fireside Ventures. The board at FS life passed a resolution to issue 10,282 Series B compulsory convertible preference shares at an issue price of Rs 34,568 each to raise the aforementioned sum, as per its regulatory filing with the Registrar of Companies (RoC). Colossa Ventures, through its Colossa WomenFirst Fund, will lead the round with an investment of Rs 10 crore, followed by Fireside Ventures with Rs 7 crore. ASA Holdings and HirePro Consulting will contribute Rs 3 crore and Rs 2.5 crore, respectively. A group of angel investors, including Rahul Garg, Rahul Kayan, and others, will also participate in the round. The company has already received Rs 9.44 crore from the above round in July from Fireside Ventures, Mirabilis Investment Trust, and others, with the remaining amount expected to be received soon. According to Entrackr's estimates, FS Life’s valuation remained flat at Rs 370 crore or $42 million post-money. Founded in 2015 by Ayushi Gudwani, FS Life is a house of women’s apparel and lifestyle brands, including FableStreet, March Jewellery, and Pinkfort. FableStreet focuses on western wear with an emphasis on perfect fits, March offers sterling silver and semi-precious jewellery, while Pinkfort caters to modern Indian wear with a contemporary take on traditional styles. According to startup data intelligence platform TheKredible, the Gurugram-based company has raised over $9.5 million to date, with Fireside Ventures as its lead investor. The company is yet to disclose its FY25 financials. In FY24, it recorded over 40% year-on-year growth in operating revenue, while its losses widened by 70% to Rs 17 crore during the same period. FS Life competes with other D2C fashion and jewellery brands such as NEWME, which raised $18 million in July last year, as well as FabAlley, Fashor (ethnic wear), and jewellery startups like GIVA and Palmonas, among others.

Docon offloads 10% stake in Thyrocare for Rs 668 Cr

EntrackrEntrackr · 3d ago
Docon offloads 10% stake in Thyrocare for Rs 668 Cr
Medial

Docon Technologies Pvt Ltd, a promoter entity of Thyrocare Technologies, has sold 53.33 lakh equity shares representing around 10% of the company’s total paid-up capital through open market transactions on October 24, 2025. The sale was valued at Rs 667.7 crore at an average price of Rs 1,252 per share, according to a stock exchange filing. Following the transaction, Docon’s shareholding in Thyrocare has come down from 71% to 61% and continues to remain a promoter of the diagnostics chain with 3.2 crore shares. The block sale saw strong participation from domestic mutual funds. Among the key buyers were ICICI Prudential Mutual Fund, which purchased 17.49 lakh shares worth Rs 218.9 crore, and Aditya Birla Sun Life Mutual Fund, which picked up 10.33 lakh shares for Rs 129.3 crore. Other prominent investors included HSBC Mutual Fund Midcap Fund (6.66 lakh shares for Rs 83.4 crore), HDFC Mutual Fund (4.44 lakh shares for Rs 55.5 crore), and Eastspring Investments India Consumer Equity Open Limited (3.19 lakh shares for Rs 40 crore). The stake sale comes on the back of leadership transition within the PharmEasy-Thyrocare group. In August 2025, PharmEasy’s co-founder and CEO Siddharth Shah stepped down from his executive role to become the company’s Vice Chairman, while Thyrocare’s chief Rahul Guha was elevated as the new MD and CEO of API Holdings, the parent entity of PharmEasy and Thyrocare. Guha continues to lead Thyrocare alongside his expanded responsibilities at API. Thyrocare recently announced its financial numbers for the second quarter of the ongoing fiscal year FY26, posting a strong performance in the quarter. The company’s revenue from operations grew 22% year-on-year (YoY) to Rs 216.5 crore in Q2 FY26 from Rs 177.36 crore in Q2 FY25. Thyrocare’s profit jumped 81% YoY to Rs 47.9 crore in Q2 FY26, compared to Rs 26.4 crore in the corresponding quarter last year. For the first half of FY26, the company recorded a net profit that grew 71% to Rs 86.1 crore from Rs 50.4 crore in H1 FY25.

Download the medial app to read full posts, comements and news.